Keyphrases
Antitumor
100%
MPGES-1
100%
Novel Therapeutic Targets
100%
Prostaglandins
100%
Prostaglandin E2
78%
Colon Cancer
47%
Cardiotoxicity
29%
Cyclooxygenase-2 Inhibitors
29%
In Cancer
19%
Antitumor Activity
19%
Biological Activity
19%
Cyclooxygenase-2
19%
Xenograft
15%
Colon Cancer Cells
15%
Role in Cancer
9%
Chemical Entities
9%
Rational Structure
9%
Tumor Growth
9%
In Vivo Model
9%
Chemical Library
9%
Cancer Cells
9%
Novel Agents
9%
High Dose
9%
Cancer Cell Growth
9%
Cancer Initiation
9%
Overexpressing
9%
Tumor Stroma
9%
Molecular Targets
9%
Tumorigenicity
9%
Mechanistic Studies
9%
Focused Library
9%
Structural Homology
9%
Drug-like Properties
9%
Homology Modeling
9%
Inflammatory Stroma
9%
Docking Simulation
9%
Cancer Progression
9%
Antitumor Properties
9%
Structure-based Design
9%
Novel Leads
9%
Pharmacophore
6%
Rational Drug Design
6%
Grant Applications
6%
Public Health
6%
Novel Inhibitors
6%
Tumor
6%
Inflammation
6%
Therapeutic Target
6%
Triclosan
6%
Anti-inflammatory Properties
6%
Dentistry
6%
Expressed Protein
6%
New Leads
6%
Molecular Modeling
6%
Orthotopic Model
6%
Mouse Tumor Model
6%
In Silico Screening
6%
Pharmacology, Toxicology and Pharmaceutical Science
Prostaglandin
100%
Molecular Target
100%
Prostaglandin E2
100%
Colon Cancer
83%
Neoplasm
58%
Malignant Neoplasm
50%
COX-2 Inhibitor
37%
Cardiotoxicity
37%
Biological Activity
25%
Cyclooxygenase 2
25%
Synthetase
12%
Carcinogenicity
12%
Epileptic Absence
12%
Lead Compound
12%
Cancer Growth
12%
Tumor Growth
12%
Inflammation
8%
Drug Development
8%
Triclosan
8%
Anti-Inflammatory Drug
8%